158 related articles for article (PubMed ID: 9156356)
1. Electrophysiologic effects of SD-3212, a new class I antiarrhythmic drug, on canine atrial flutter and atrial action-potential characteristics.
Fujiki A; Tani M; Hayashi H; Mizumaki K; Inoue H; Uemura H; Nakaya H
J Cardiovasc Pharmacol; 1997 Apr; 29(4):471-5. PubMed ID: 9156356
[TBL] [Abstract][Full Text] [Related]
2. Effects of antiarrhythmic drugs on canine atrial flutter due to reentry: role of prolongation of refractory period and depression of conduction to excitable gap.
Inoue H; Yamashita T; Nozaki A; Sugimoto T
J Am Coll Cardiol; 1991 Oct; 18(4):1098-104. PubMed ID: 1910060
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiologic effects of the new class III antiarrhythmic drug dofetilide compared to the class IA antiarrhythmic drug quinidine in experimental canine atrial flutter: role of dispersion of refractoriness in antiarrhythmic efficacy.
Cha Y; Wales A; Wolf P; Shahrokni S; Sawhney N; Feld GK
J Cardiovasc Electrophysiol; 1996 Sep; 7(9):809-27. PubMed ID: 8884510
[TBL] [Abstract][Full Text] [Related]
4. Effects of procainamide on the excitable gap composition in a canine model of atrial flutter.
Jalil E; Laflamme M; Kus T
Can J Physiol Pharmacol; 1997 Jan; 75(1):1-8. PubMed ID: 9101058
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiologic effects of a new class III antiarrhythmic agent, E-4031, on atrial flutter, atrial refractoriness, and conduction delay in a canine sterile pericarditis model.
Shimizu A; Kaibara M; Centurion OA; Kapuku G; Hirata T; Fukatani M; Yano K; Hashiba K
J Cardiovasc Pharmacol; 1993 Apr; 21(4):656-62. PubMed ID: 7681913
[TBL] [Abstract][Full Text] [Related]
6. Antiarrhythmic drugs preferentially produce conduction block at the area of slow conduction in the re-entrant circuit of canine atrial flutter: comparative study of disopyramide, flecainide, and E-4031.
Inoue H; Yamashita T; Usui M; Nozaki A; Sugimoto T
Cardiovasc Res; 1991 Mar; 25(3):223-9. PubMed ID: 1903082
[TBL] [Abstract][Full Text] [Related]
7. Effects of N-acetylprocainamide and recainam in the pharmacologic conversion and suppression of experimental canine atrial flutter: significance of changes in refractoriness and conduction.
Feld GK; Venkatesh N; Singh BN
J Cardiovasc Pharmacol; 1988 May; 11(5):573-80. PubMed ID: 2455844
[TBL] [Abstract][Full Text] [Related]
8. Role of anisotropy in determining the selective action of antiarrhythmics in atrial flutter in the dog.
Yamashita T; Inoue H; Nozaki A; Kuo TT; Usui M; Sugimoto T
Cardiovasc Res; 1992 Mar; 26(3):244-9. PubMed ID: 1423419
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiologic and antiarrhythmic effects of the new class III antiarrhythmic drug KCB-328 in experimental canine atrial flutter.
Rahme MM; Ungab GA; Wadhwa M; Al-Kandari F; Yao B; Gupta A; Lee K; Kim HY; Feld GK
J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):297-306. PubMed ID: 11584336
[TBL] [Abstract][Full Text] [Related]
10. SD-3212, a new class I and IV antiarrhythmic drug: a potent inhibitor of the muscarinic acetylcholine-receptor-operated potassium current in guinea-pig atrial cells.
Hara Y; Nakaya H
Br J Pharmacol; 1995 Nov; 116(6):2750-6. PubMed ID: 8591000
[TBL] [Abstract][Full Text] [Related]
11. Effects of a novel class III antiarrhythmic agent, NIP-142, on canine atrial fibrillation and flutter.
Nagasawa H; Fujiki A; Fujikura N; Matsuda T; Yamashita T; Inoue H
Circ J; 2002 Feb; 66(2):185-91. PubMed ID: 11999646
[TBL] [Abstract][Full Text] [Related]
12. The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model.
Rossman EI; Liu K; Morgan GA; Swillo RE; Krueger JA; Gardell SJ; Butera J; Gruver M; Kantrowitz J; Feldman HS; Petersen JS; Haugan K; Hennan JK
J Pharmacol Exp Ther; 2009 Jun; 329(3):1127-33. PubMed ID: 19252062
[TBL] [Abstract][Full Text] [Related]
13. Characterization of low right atrial isthmus as the slow conduction zone and pharmacological target in typical atrial flutter.
Tai CT; Chen SA; Chiang CE; Lee SH; Ueng KC; Wen ZC; Huang JL; Chen YJ; Yu WC; Feng AN; Chiou CW; Chang MS
Circulation; 1997 Oct; 96(8):2601-11. PubMed ID: 9355900
[TBL] [Abstract][Full Text] [Related]
14. Electropharmacologic effects of class I and class III antiarrhythmia drugs on typical atrial flutter: insights into the mechanism of termination.
Tai CT; Chen SA; Feng AN; Yu WC; Chen YJ; Chang MS
Circulation; 1998 May; 97(19):1935-45. PubMed ID: 9609087
[TBL] [Abstract][Full Text] [Related]
15. In vivo cardiac electrophysiologic and antiarrhythmic effects of an isoquinoline IKur blocker, ISQ-1, in rat, dog, and nonhuman primate.
Regan CP; Stump GL; Wallace AA; Anderson KD; McIntyre CJ; Liverton NJ; Lynch JJ
J Cardiovasc Pharmacol; 2007 Apr; 49(4):236-45. PubMed ID: 17438409
[TBL] [Abstract][Full Text] [Related]
16. Azd7009: a new antiarrhythmic drug with predominant effects on the atria effectively terminates and prevents reinduction of atrial fibrillation and flutter in the sterile pericarditis model.
Goldstein RN; Khrestian C; Carlsson L; Waldo AL
J Cardiovasc Electrophysiol; 2004 Dec; 15(12):1444-50. PubMed ID: 15610294
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of antiarrhythmic drug action on termination of atrial flutter.
Tai CT; Chen SA
Pacing Clin Electrophysiol; 2001 May; 24(5):824-34. PubMed ID: 11388102
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiologic properties of UK-66,914, a novel class III antiarrhythmic agent.
Gwilt M; Dalrymple HW; Burges RA; Blackburn KJ; Dickinson RP; Cross PE; Higgins AJ
J Cardiovasc Pharmacol; 1991 Mar; 17(3):376-85. PubMed ID: 1711597
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic suppression of atrial flutter induced by atrial stimulation.
Davis WR; Schaal SF
Am Heart J; 1992 Mar; 123(3):681-6. PubMed ID: 1539519
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction.
Feld GK; Venkatesh N; Singh BN
Circulation; 1986 Jul; 74(1):197-204. PubMed ID: 3708774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
